Back

Regeneron Pharmaceuticals
REGN
$954.53
0.22%
Overview
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The Company's commercialized medicines...
Open
$951.50
Prior close
$952.40
Today's high
$965.17
Today's low
$948.42
52 Week high
$991.73
52 Week low
$591.52
News
MarketBeat • 1 hour ago • REGN
Regeneron Pharmaceuticals Sees Growth Ahead, Eyes EYLEA HD Syringe Approval

Seeking Alpha • 2 hours ago • REGN
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

GlobeNewsWire • 8 hours ago • REGN
Libtayo® (cemiplimab) Approved in the European Union (EU) for Extended Dosing and Faster Infusion Times Across Skin, Lung and Cervical Cancer Indications

FXEmpire • 22 hours ago • REGN
REGN Price Forecast: Rally Faces Resistance After 37% Advance

The Motley Fool • 3 days ago • REGN
Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech?
